Drug developer Gilead soars to 16-month high after WHO official says its experimental treatment is best shot for fighting coronavirus (GILD)

Business Insider

Published

· *Biotech company Gilead soared as much as 6.9% Monday morning after a World Health Organization official made a hopeful comment on its experimental coronavirus treatment.*
· *The drug developer's remdesivir compound is the "one drug right now that we think may have efficacy," Bruce Aylward, an assistant director-general at...

Full Article